151-01-9

Basic information

• Product Name: O-ethyl hydrogen dithiocarbonate
• Synonyms: O-ethyl hydrogen dithiocarbonate;ethyl dithiocarbonate;ETHYLXANTHOGENATE;Carbonodithioic acid O-ethyl;Ethylxanthic acid;140-89-6 (Potassium salt);140-90-9 (Hydrochloride salt);Brn 1740597
• CAS NO: 151-01-9
• Molecular Formula: C₃H₆OS₂
• Molecular Weight: 122.20914
• EINECS: 205-780-8
• Mol File: 151-01-9.mol
• Article Data: 30

Chemical Properties

• Melting Point: 140 °C
• Boiling Point: 197.67°C (rough estimate)
• Flash Point: 26.7 °C
• Appearance: /
• Density: 1.194 (estimate)
• Vapor Pressure: 18.2mmHg at 25°C
• Refractive Index: 1.5700 (estimate)
• PKA: 3.19±0.60(Predicted)
• CAS DataBase Reference: O-ethyl hydrogen dithiocarbonate(CAS DataBase Reference)
• NIST Chemistry Reference: O-ethyl hydrogen dithiocarbonate(151-01-9)
• EPA Substance Registry System: O-ethyl hydrogen dithiocarbonate(151-01-9)

Safety Data

• Hazardous Substances Data: 151-01-9(Hazardous Substances Data)

Usage

General Description

O-ethyl hydrogen dithiocarbonate is a chemical compound with the molecular formula C3H6OS2. It is a dithiocarbamate derivative, which is a type of organic sulfur compound with a characteristic R2NCS2- structure. O-ethyl hydrogen dithiocarbonate is commonly used as a reagent in organic synthesis and as a flotation reagent in mineral processing. It is also used as an intermediate in the production of pesticides, fungicides, and rubber chemicals. The compound is considered to be moderately hazardous, as it can cause irritation to the skin, eyes, and respiratory system upon exposure, and it may also have toxic effects if ingested or inhaled in large amounts.

InChI:InChI=1/C3H6OS2/c1-2-4-3(5)6/h2H2,1H3,(H,5,6)

Upstream product

• 502-55-6 bis-ethoxythiocarbonyldisulfane 
• 62-53-3 aniline 
• 60-29-7 diethyl ether 
• 463-56-9 thiocyanic acid 
• 75-00-3 chloroethane 
• 71697-84-2 (-)-trans-sobrerol 
• 140-89-6 potassium ethyl xanthogenate 
• 1091610-09-1 bis(O-ethylxanthato)nickel(II) 
• 4091-39-8 3-chloro-2-butanone 
• 70-11-1 α-bromoacetophenone 
• 136490-79-4 S-trimethylsilyl O-ethyldithiocarbonate 
• 75-15-0 carbon disulfide 
• 64-17-5 ethanol 

Downstream Products

• 75-15-0 carbon disulfide 
• 64-17-5 ethanol 
• 106-45-6 para-thiocresol 
• 502-55-6 bis-ethoxythiocarbonyldisulfane 
• 73232-07-2 2-ethoxythiocarbonyl sulfanyl-propionic acid ethyl ester 
• 52696-69-2 Dithiocarbonic acid S-[3,3-diallyl-1-(4-chloro-phenyl)-ureidomethyl] ester O-ethyl ester 
• 21504-76-7 1-(2,4-Dimethyl-phenyl)-dithiobiuret 
• 875851-19-7 ω-(4-Dimethylamino-phenyl)-dithiobiuret 
• 132277-76-0 O-ethyl S-triphenylmethyl dithiocarbonate 
• 57494-94-7 1-(2-methoxy-phenyl)-dithiobiuret 
• 82585-22-6 3,5-bis-benzylmercapto-[1,2,4]thiadiazole 
• 136228-16-5 5-O-Benzoyl-2,3-dideoxy-2-fluoro-1-O-methyl-β-D-threo-pentofuranose 

Relevant articles and documents

Reaction-induced microphase separation in polybenzoxazine thermosets containing poly(N-vinyl pyrrolidone)-block-polystyrene diblock copolymer

Poly(N-vinyl pyrrolidone)- block-polystyrene diblock copolymer (PVPy- b-PS) was synthesized via sequential reversible radical-fragmentation transfer polymerization with S-1-phenylethyl O-ethylxanthate as a chain transfer agent. The block copolymer was incorporated into polybenzoxazine to access the nanostructures in the thermosets. The nanostructures in the thermosets were investigated by means of transmission electron microscopy (TEM) and small-angle X-ray scattering (SAXS). It was found that disordered and/or ordered PS nanophases were formed in the PBa thermosets. It is judged that the formation of nanophases followed the mechanism of reaction-induced microphase separation in terms of the miscibility of the subchains of the diblock copolymer (viz. PVPy and PS) with polybenzoxazine after and before curing reaction.

Sulphonamido-Substituted Cyclohexyl Sulphones for Treatment of Cancer

Compounds of formula (I) are disclosed for treatment of cancer.

Modulators of LXR

Compounds of the invention, such as compounds of formula (I): where n, m, A, B, R1, R2, R3, R4 and R5 are defined herein, are useful as modulators of the activity of liver X receptors. Pharmaceutical compositions containing the compounds and methods of using the compounds are also disclosed.